Association of Hemoglobin A1c, 1,5-Anhydro-D-Glucitol and Glycated Albumin with Oxidative Stress in Type 2 Diabetes Mellitus Patients: A Cross-Sectional Study.
1,5-Anhydro-D-glucitol
Diacron-reactive oxygen metabolites
Glycated albumin
Oxidative stress
Type 2 diabetes mellitus
Journal
Diabetes therapy : research, treatment and education of diabetes and related disorders
ISSN: 1869-6953
Titre abrégé: Diabetes Ther
Pays: United States
ID NLM: 101539025
Informations de publication
Date de publication:
Mar 2020
Mar 2020
Historique:
received:
12
12
2019
pubmed:
31
1
2020
medline:
31
1
2020
entrez:
31
1
2020
Statut:
ppublish
Résumé
Oxidative stress plays a central role in the development and progression of vascular complications in patients with type 2 diabetes mellitus (T2DM). We have previously shown that markers of glucose variability evaluated by continuous glucose monitoring (CGM) are positively associated with oxidative stress in patients with T2DM. However, the evaluation of the glycemic variability by CGM remains a time- and money-consuming procedure. Therefore, this study investigated the independent correlates of oxidative stress among various other clinical markers routinely measured in primary care. This was a retrospective cross-sectional study with 234 T2DM patients to examine which clinical variables, including 1,5-anhydro-D-glucitol (1,5-AG) and glycated albumin (GA), were independently associated with oxidative stress. Oxidative stress was measured using the diacron-reactive oxygen metabolites (d-ROMs) test. The relationships between d-ROMs and clinical factors, such as blood glucose, glycated hemoglobin (HbA1c), 1,5-AG, GA, lipid parameters, and blood pressure, were examined. Multiple stepwise regression analysis revealed that 1,5-AG (inversely), GA, triglycerides, use of metformin and being female were independently associated with d-ROMs. When patients with T2DM were stratified into two groups with HbA1c < 8.0% and HbA1c ≥ 8.0%, 1,5-AG (inversely), HbA1c, use of metformin and being female were independently associated with d-ROMs in diabetes patients with HbA1c < 8.0%, whereas GA, fasting plasma glucose and being female were independently associated with d-ROMs in patients with HbA1c ≥ 8.0%. Our present study suggests that 1,5-AG and GA are the strongest correlates of oxidative stress in patients with well and poorly controlled T2DM, respectively.
Identifiants
pubmed: 31997224
doi: 10.1007/s13300-020-00772-7
pii: 10.1007/s13300-020-00772-7
pmc: PMC7048877
doi:
Types de publication
Journal Article
Langues
eng
Pagination
655-665Subventions
Organisme : Grants-in-Aid for Scientific Research
ID : 17K08968
Références
J Clin Endocrinol Metab. 2011 Nov;96(11):3448-56
pubmed: 21865372
Diabetes Res Clin Pract. 2016 Dec;122:62-70
pubmed: 27810687
Acta Diabetol. 2016 Dec;53(6):973-979
pubmed: 27573202
Biochem Biophys Res Commun. 2010 May 28;396(2):199-205
pubmed: 20398632
Atherosclerosis. 2014 Jan;232(1):156-64
pubmed: 24401231
Diabetes Care. 2003 Mar;26(3):881-5
pubmed: 12610053
Expert Rev Mol Diagn. 2008 Jan;8(1):9-19
pubmed: 18088226
Diabetes. 2008 May;57(5):1349-54
pubmed: 18299315
Lancet. 2010 Jun 26;375(9733):2215-22
pubmed: 20609967
Diabetes Care. 2006 Jun;29(6):1214-9
pubmed: 16731998
Hypertens Res. 2011 Sep;34(9):1041-5
pubmed: 21677660
PLoS One. 2012;7(9):e46517
pubmed: 23029543
Diabetes Res Clin Pract. 2011 Jul;93(1):56-62
pubmed: 21146883
Chin Med J (Engl). 2011 Nov;124(22):3641-5
pubmed: 22340217
Cardiovasc Diabetol. 2015 Feb 07;14:16
pubmed: 25851542
Diabetologia. 2006 May;49(5):846-54
pubmed: 16532323
Diabet Med. 2005 Oct;22(10):1347-53
pubmed: 16176195
Cardiovasc Diabetol. 2013 Jan 02;12:1
pubmed: 23280391
Diabetes Care. 1996 Mar;19(3):257-67
pubmed: 8742574
Med Princ Pract. 2010;19(6):496-8
pubmed: 20881421
Diabetol Metab Syndr. 2014 Dec 15;6(1):139
pubmed: 25530811
J Diabetes Investig. 2010 Oct 19;1(5):212-28
pubmed: 24843435
Lancet. 2014 Aug 16;384(9943):626-635
pubmed: 25131982
Lancet. 1998 Sep 12;352(9131):854-65
pubmed: 9742977
Int Angiol. 1999 Jun;18(2):127-30
pubmed: 10424368
Diabetes Metab. 2015 Dec;41(6 Suppl 1):6S9-6S15
pubmed: 26774019
J Diabetes Complications. 2016 Nov - Dec;30(8):1452-1455
pubmed: 27591029
Circ J. 2007 Jul;71(7):1067-73
pubmed: 17587712
Endocr J. 2010;57(2):135-40
pubmed: 19926921
Diabetes Res Clin Pract. 2018 May;139:253-261
pubmed: 29501829
Nephron. 1976;16(1):31-41
pubmed: 1244564
J Atheroscler Thromb. 2012;19(8):712-7
pubmed: 22785135
Diabetes Metab Res Rev. 2011 May;27(4):348-53
pubmed: 21309055
Diabetes Metab. 2014 Sep;40(4):272-7
pubmed: 24630733
J Diabetes Complications. 2014 Nov-Dec;28(6):772-8
pubmed: 25073934
Cardiovasc Diabetol. 2019 Jun 3;18(1):69
pubmed: 31159826
Cardiovasc Diabetol. 2011 Feb 25;10:19
pubmed: 21349201
J Diabetes Investig. 2013 Nov 27;4(6):634-9
pubmed: 24843719
Int J Cardiol. 2006 Jun 28;110(3):415-6
pubmed: 16293325
Clin Chim Acta. 2014 Jun 10;433:96-104
pubmed: 24631132
Diabetes Nutr Metab. 2000 Aug;13(4):182-5
pubmed: 10961484
Cardiovasc Diabetol. 2014 Jun 13;13:99
pubmed: 24924149
Atherosclerosis. 2011 Jun;216(2):477-83
pubmed: 21414624
Diabetes Care. 2003 Nov;26(11):3160-7
pubmed: 14578255
Atherosclerosis. 2014 Nov;237(1):361-8
pubmed: 25443874
Clin Biochem. 2005 Jan;38(1):88-91
pubmed: 15607323
Clin Nutr. 2013 Apr;32(2):179-85
pubmed: 22963881
Diabetes Care. 2019 Aug;42(8):1436-1445
pubmed: 31167893
Clin Chem Lab Med. 2002 Feb;40(2):104-10
pubmed: 11939481